Opioid and benzodiazepine use in gynecologic oncology patients.
Khrystyna LevytskaSavannah R PenaJubilee BrownZiqing YuMeghan K WallyJoseph R HsuRachel B SeymourR Wendel Naumannnull nullPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Opioid and benzodiazepine prescribing patterns differ for cervical, ovarian, and uterine cancer patients. Gynecologic oncology patients are overall at low risk for opioid misuse; however, patients with cervical cancer are more likely to have risk factors present for opioid misuse.